Drug intelligence / Profile preview

AmniPur

Development stage
Unknown
Lead developer
PrimeCell Advanced Therapy
Administration
Topical
01

Overview

AmniPur is a patented amniotic membrane-based biological matrix and tissue preservation technology developed by PrimeCell Advanced Therapy and its spin-off BioHealing. It is used to manufacture Amnioderm and Amnioderm+, which are freeze-dehydrated human amniotic membrane allografts. The AmniPur technology preserves the essential biological and regenerative properties of the amniotic membrane, including growth factors and cytokines, while ensuring sterility and a long shelf-life at room temperature. It is designed to support wound healing and tissue repair by providing a biocompatible scaffold that promotes re-epithelialization, neovascularization, and anti-inflammatory effects. Amnioderm is utilized in the treatment of hard-to-heal chronic wounds (such as diabetic foot ulcers and venous ulcers), burns, and toxic epidermal necrolysis.

Brand names
AmniPurAmniodermAmnioderm+
Other names
Amniotic membrane-based material

Beyond the preview

Go deeper on AmniPur.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on AmniPur.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call